Shopping Cart
Remove All
Your shopping cart is currently empty
Foslinanib Sodium (TRX818 Sodium) is an anticancer compound.It inhibits vasculogenic mimicry network formation in C8161 and SK-MEL-28 melanoma cells when used at concentrations ranging from less than or equal to 5 to 10 nM

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $202 | In Stock | In Stock | |
| 5 mg | $412 | In Stock | In Stock | |
| 10 mg | $613 | In Stock | In Stock | |
| 25 mg | $977 | In Stock | In Stock | |
| 50 mg | $1,320 | In Stock | In Stock | |
| 100 mg | $1,780 | In Stock | - |
| Description | Foslinanib Sodium (TRX818 Sodium) is an anticancer compound.It inhibits vasculogenic mimicry network formation in C8161 and SK-MEL-28 melanoma cells when used at concentrations ranging from less than or equal to 5 to 10 nM |
| Synonyms | TRX818 Sodium |
| Molecular Weight | 409.21 |
| Formula | C16H11FNNa2O6P |
| Cas No. | 1256037-62-3 |
| Smiles | O=C1C=C(C2=CC=CC(F)=C2)NC3=C1C(OP([O-])([O-])=O)=C(OC)C=C3.[Na+].[Na+] |
| Relative Density. | no data available |
| Color | White |
| Appearance | solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (122.19 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.